Envestnet Portfolio Solutions
TAK icon

Envestnet Portfolio Solutions’s Takeda Pharmaceutical TAK Stock Holding History

Envestnet Portfolio Solutions’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
12,997
-1,546
-11% -$25.6K ﹤0.01% 1351
2026
Q1 		$269K Sell
14,543
-12,844
-47% -$225K ﹤0.01% 1157
2025
Q4 		$427K Buy
27,387
+8,867
+48% +$127K ﹤0.01% 1125
2025
Q3 		$271K Buy
18,520
+3,408
+23% +$50.6K ﹤0.01% 1297
2025
Q2 		$234K Buy
15,112
+3,410
+29% +$50.4K ﹤0.01% 1443
2025
Q1 		$174K Sell
11,702
-11,914
-50% -$167K ﹤0.01% 1513
2024
Q4 		$313K Sell
23,616
-2,119
-8% -$29.1K ﹤0.01% 1486
2024
Q3 		$366K Sell
25,735
-4,135
-14% -$58.7K ﹤0.01% 1347
2024
Q2 		$387K Buy
29,870
+4,107
+16% +$54.4K ﹤0.01% 1241
2024
Q1 		$358K Buy
25,763
+1,778
+7% +$25.9K ﹤0.01% 1263
2023
Q4 		$342K Buy
23,985
+1,626
+7% +$23.1K ﹤0.01% 1228
2023
Q3 		$346K Buy
+22,359
New +$346K ﹤0.01% 1155

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Envestnet Portfolio Solutions's TAK Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its Takeda Pharmaceutical (TAK) stake by 11% in Q2 2026, selling an estimated $25.6K and leaving 12,997 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Envestnet Portfolio Solutions first reported a position in TAK in Q3 2023 and has held it in 12 quarters since. The position peaked at $427K in Q4 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Envestnet Portfolio Solutions held 12,997 shares of Takeda Pharmaceutical worth $208K as of Q2 2026.
  • Envestnet Portfolio Solutions sold 1,546 Takeda Pharmaceutical shares in Q2 2026, an estimated $25.6K.
  • Takeda Pharmaceutical made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #1351 holding.
  • Envestnet Portfolio Solutions first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Takeda Pharmaceutical position peaked at $427K in Q4 2025.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.